Skip to content

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

A Randomized Control Trial Comparing Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy Delivered Online

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04000217
Enrollment
130
Registered
2019-06-27
Start date
2020-01-20
Completion date
2022-09-09
Last updated
2023-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Imaginal Exposure Therapy, Written Exposure Therapy

Brief summary

The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coaching from a trained peer support specialist. Treatment will be a variable length, such that 4 to 8 sessions will be delivered, depending on each participants' rate of PTSD symptom recovery.

Interventions

BEHAVIORALWritten Exposure Therapy

In this study, written exposure therapy is delivered in an online format with coaching from trained peer support specialists. Participants will complete 4-8 sessions, depending on their level of symptom reduction (i.e., allow for early termination when low symptom levels are achieved).

Delivery of imaginal exposure in this study will mirror the procedures used in WET. It will be delivered in an online format with coaching from trained peer support specialists. Participants will complete 4-8 sessions, depending on their level of symptom reduction (i.e., allow for early termination when low symptom levels are achieved).

Sponsors

Palo Alto Veterans Institute for Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Able to read/write English * Internet connection allowing stable access to the Vets Prevail website * A clinically significant PCL-5 score of 31 or above.

Exclusion criteria

* A score on the suicidality item of the PHQ-9 of 3 or higher.

Design outcomes

Primary

MeasureTime frameDescription
Post Traumatic Stress Disorder CheckList for Diagnostic and Statistical Manual - 5 (PCL-5; Weathers, et al., 2013)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).Self report measure of PTSD symptoms. A total symptom severity score (range - 0-80) can be obtained by summing the scores for each of the 20 items. Higher scores indicate greater PTSD severity.

Secondary

MeasureTime frameDescription
Patient Health Questionnaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001).Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).Self report measure of depression symptoms. It is the 9-item measure that yields a total score of 0-27, with higher scores indicating greater depressive symptom severity.
Brief version of the difficulties in emotion regulation scale (DERS-16; Bjureberg et al,. 2016)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).A 16-item self report measure of difficulties in emotion regulation. Total scores on the DERS-16 can range from 16 to 80, with higher scores reflecting greater levels of emotion dysregulation.
Work and Social Adjustment Scale (WSAS; Mundt et al., 2002)Change in total score from baseline to 3-months post treatment (approximately 14-18 weeks).A 5-item self-report measure of work and social functioning and impact of symptoms. Total scores range from 0-40 with higher scores indicating greater impairment.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026